Collection of samples and data across the following diseases: Malignant tumour of breast Randomised, double-blind, multicentre phase III trial evaluating the safety and benefit of adding everolimus to adjuvant hormone therapy in women with high risk of relapse, ER+ and HER2- primary breast cancer who remain free of disease (UNIRAD).
collection sample malignant tumour of breast uk unirad